USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bayer Animal Health GmbH

USPTO PatentsView assignee record - 40 granted patents across 15 technology areas, recorded in grant years 2017–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Bayer ranks #7,982 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 15 technology areas.

#7,982
of 49,997 US assignees by volume
Top 32%
by Innovation Score (41.7/100)
17.6
avg claims per patent
+86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7982 · Foreign Corporation #7,982 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 40 grants
  • UPPER-Q #7,982/49,997
  • PHOTO-FINISH Belgravia Wood
  • CPC-FOCUS A61P · 15 areas
  • INNOV-PAR 41.7/100
  • CLAIMS-RICH 17.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +86% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Belgravia Wood Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bayer’s 41.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Bayer

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Bayer's Innovation Score is 41.7/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Bayer?

Each dot is one of Bayer’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bayer’s own 17.6 claims/patent is ABOVE the 9.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bayer vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 39.940.040.04040.040.040.1 0510152025 Granted patents (volume) Avg claims / patent Bial-portela & CA, S.A. - 40, 19.15Bial-portela & CABIG Lift, LLC - 40, 6.62BIG LiftBromine Compounds Ltd. - 40, 12.12Bromine CompoundsByton Limited - 40, 9.95BytonBelgravia Wood Limited - 40, 17.5Belgravia WoodBreathableBaby, LLC - 40, 8.93BreathablebabyCambria County Association FOR THE Blind AND Handicapped - 40, 5.28Cambria County As…Cantor Index, LLC - 40, 23.6Cantor IndexBayer Animal Health GmbH - 40, 17.55Bayer Animal Heal…
Bayer vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bayer's grants concentrate

Bayer Animal Health GmbH is a focused PatentsView assignee: 15 CPC subclasses with 75% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (10 grants) versus a trough of 2 in 2018. By volume, Bayer sits between Bial-portela & CA, S.A. and Cantor Index, LLC.

Bayer's three-year grant acceleration

From 2019–2021 to 2022–2024, Bayer Animal Health GmbH moved from 20 to 14 grants (0.70x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Bayer's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Bayer holds 40 patents at rank #7,987, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Bayer

By rank, the assignees closest to #7,987 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Bayer's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bayer, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Bayer ranks #655 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Bayer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 2017201820192020202120222023 4
USPTO utility patent grants by year · 2017–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Bayer Animal Health GmbH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 4 10.0%
2018 2 5.0%
2019 8 20.0%
2020 6 15.0%
2021 6 15.0%
2022 10 25.0%
2023 4 10.0%

Which technologies does Bayer Animal Health GmbH patent most?

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Bayer Animal Health GmbH's patent record in context - here's where to go next.

  • Bayer Animal Health GmbH's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 75% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #7,982 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Bayer Animal Health GmbH against Bial-portela & CA, S.A., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 41.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.